NEXUSBioMed,
in partnership with HUMANeX Ventures®, announces the launch of a comprehensive
study of organizations that are committed to pursuing excellence and becoming
industry leaders within the pharmaceutical, biotechnology, medical device, and
nanotechnology industries.
Organizations selected to take part in the study will benefit from a partnership
with NEXUSBioMed, a highly-specialized boutique executive search firm specializing
in the physical and life sciences, and Kalamazoo-based HUMANeX Ventures®,
a leading talent-driven consulting, training, coaching, research, and assessment
firm.
Participating companies will be provided with an innovative, integrated approach
to talent search, acquisition, and development as the results are measured and
assessed. Their teams will be studied through structured interviews that help
identify and define their top performers and the attributes that make them excellent
in their roles. Their organizational cultures will be analyzed by HUMANeX Ventures®
and leaders will be provided with feedback about how to take it to the next
level.
As data is collected about the overall growth and improvement of each organization
over time, the results will be published by the NEXUSBioMed/HUMANeX Ventures®
partnership.
NEXUSBioMed is led by Adriana Petersen, a reputable search professional with
more than 25 years of experience and in excess of 3,000 successful placements
world-wide, and Michael Terlaak, a seasoned entrepreneur with a 20-year track
record of successful ventures in a range of industries who leads the company’s
NEXUSNanoTec division.
“We will work with companies that are motivated by achieving excellence,”
said Terlaak. “Through our years of success and expertise in executive
recruitment and our partnership with HUMANeX, we have the tools to take these
promising organizations to the next level and help them achieve their greatest
potential.”
“Through this study, we will apply our shared expertise and these companies
will experience a level of growth, development, and success that was previously
just out of reach,” added Petersen. “We can help them make that
giant step toward greatness – then we’ll publish their accomplishments
so the world can see that they are committed to success and excellence.”
The partnership currently is sourcing and selecting organizations within the
following categories to participate in the study:
Organizations emerging from early-stage, entering or ready to enter into the
commercialization phase Mid-size companies with a great, high-potential products,
services or technology but lacking proper culture and necessary leadership to
take the organization to the next level Stand-alone divisions of major organizations
with their own P&L, as well as internal decision-making capabilities Organizations
with great technology, products or services, but struggling to succeed.
To be considered for selection into this study, organizations must be willing
to commit their time and make the financial investment associated with executive
search and talent development services. In addition, organizations must agree
to participate in the tracking, journaling and compilation of their practices
to measure and demonstrate the application and success of the methodologies
applied by NEXUSBioMed and HUMANeX Ventures®, as well as providing the partnership
the right to publish the positive results.
“Our goal in this comprehensive study is to apply our combined instruments
and expertise to the growth and success of companies in the sciences across
America, then track the results and share with the world what is possible when
you apply disciplined action to the pursuit of excellence,” said HUMANeX
Ventures® President, CEO and founder, Brad Black. “We are eager to
share these processes, tools and information and to change the face of the physical
and life science industries.”
Black founded HUMANeX Ventures® to combine more than 25 years of his own
experience in the development of human capital and building cultures of excellence
with the expertise of a team of seasoned “Practitioner Scientists”
who have driven scientifically-grounded talent selection practices for organizations
across the country.
For additional information or if you believe your organization or an organization
you know of should be considered for this study, please contact Michael Terlaak,
Senior Partner at NEXUSBioMed at michael.terlaak@nbmsearch.com or Adriana Petersen,
Managing Partner at NEXUSBioMed at a.petersen@nbmsearch.com. All inquiries will
be handled in strict confidentiality.
Posted September 22nd, 2009
